v3.25.4
Schedule I: Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities      
Net loss $ (68,295) $ (15,070) $ (164,438)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Equity-based compensation 11,536 13,602 10,534
Deferred tax (benefit) expense 0 (301) 123,124
Tax receivable liability adjustment 3,711 (547) 100,223
Changes in operating assets and liabilities, net of amounts acquired:      
Accrued expenses and other liabilities (18,758) (9,842) (29,716)
Net cash provided by (used in) operating activities (5,120) 123,524 30,935
Investing Activities      
Net cash used in investing activities (31,902) (25,228) (39,796)
Financing Activities      
Other 171 1,322 (1,201)
Net cash provided by (used in) financing activities 42,037 (99,242) 25,596
Net change in cash and cash equivalents 7,493 (1,798) 17,253
Cash and cash equivalents at beginning of period 34,655 36,453 19,200
Cash and cash equivalents at end of period 42,148 34,655 36,453
Supplemental Cash Flow Information      
Establishment of liabilities under tax receivable agreement 0 547 0
Parent Company      
Operating Activities      
Net loss (67,360) (14,718) (154,079)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Equity in net loss of subsidiaries 56,153 186 114,697
Equity-based compensation 11,536 13,602 10,534
Deferred tax (benefit) expense 0 (57) 123,124
Tax receivable liability adjustment (427) 547 (100,223)
Changes in operating assets and liabilities, net of amounts acquired:      
Income tax receivable 0 110 7,219
Due from related parties, net 2,121 5,778 436
Accrued expenses and other liabilities 0 (374) 370
Net cash provided by (used in) operating activities 2,023 5,074 2,078
Investing Activities      
Net cash used in investing activities 0 0 0
Financing Activities      
Tax receivable agreement payments 0 (8,960) (4)
Proceeds from exercise of equity-based options 227 1,410 749
Other (22) 0 0
Net cash provided by (used in) financing activities 205 (7,550) 745
Net change in cash and cash equivalents 2,228 (2,476) 2,823
Cash and cash equivalents at beginning of period 1,258 3,734 911
Cash and cash equivalents at end of period 3,486 1,258 3,734
Supplemental Cash Flow Information      
Establishment of liabilities under tax receivable agreement $ 0 $ 547 $ 0